Protagonist Therapeutics Inc (PTGX) — Financial Flexibility Index
Protagonist Therapeutics Inc (PTGX) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-1.85 Million (operating CF $-1.94 Million minus capex $88.00K) represents 0% of total liabilities ($56.25 Million). Check asset allocation strategy of Protagonist Therapeutics Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Protagonist Therapeutics Inc Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Protagonist Therapeutics Inc across 11 annual periods. See working capital position of Protagonist Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Protagonist Therapeutics Inc (2014–2024)
Year-by-year free cash flow to debt coverage for Protagonist Therapeutics Inc. For the full company profile including market capitalisation, see Protagonist Therapeutics Inc (PTGX) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.67x | $185.51 Million | $184.15 Million | $69.43 Million | ▲ +181.6% |
| 2023 | -3.27x | $-69.63 Million | $-70.24 Million | $21.27 Million | ▲ +1.5% |
| 2022 | -3.32x | $-107.34 Million | $-108.14 Million | $32.32 Million | ▼ -48.3% |
| 2021 | -2.24x | $-106.76 Million | $-107.86 Million | $47.67 Million | ▼ -39.5% |
| 2020 | -1.61x | $-72.01 Million | $-72.48 Million | $44.86 Million | ▼ -196.6% |
| 2019 | -0.54x | $-40.56 Million | $-41.53 Million | $74.95 Million | ▲ +70.5% |
| 2018 | -1.83x | $-49.46 Million | $-49.95 Million | $26.96 Million | ▼ -1842.7% |
| 2017 | 0.11x | $4.54 Million | $3.87 Million | $43.10 Million | ▲ +102.3% |
| 2016 | -4.60x | $-29.59 Million | $-29.97 Million | $6.43 Million | ▼ -72.6% |
| 2015 | -2.66x | $-13.99 Million | $-14.38 Million | $5.25 Million | ▲ +15.1% |
| 2014 | -3.14x | $-7.44 Million | $-7.74 Million | $2.37 Million | — |